Plain-English translation of NCT06964438 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After abdominal surgery for colorectal or stomach cancer, patients naturally lose muscle mass during recovery. This trial is testing whether neuromuscular electrical stimulation (NMES)—a device that sends gentle electrical pulses to make your muscles contract—can reduce this muscle loss. The researchers also want to know if adding protein-rich drinks alongside the stimulation treatment works even better.
Muscle loss after major surgery can slow recovery, reduce strength, and affect how well patients function in daily life. This trial aims to find out if the stimulation treatment can protect muscle during this critical recovery window and help patients bounce back faster.
You likely qualify if…
You likely don't qualify if…
You'll visit the hospital once before surgery for baseline measurements, including an ultrasound of your thigh muscle. After surgery, from days 1 to 4, you'll be randomly assigned to one of three groups: standard care only, standard care plus twice-daily electrical stimulation sessions plus a placebo drink, or standard care plus twice-daily stimulation sessions plus protein drinks. On day 5 after surgery, you'll return for repeat ultrasound measurements to see how much muscle you've maintained.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
United Kingdom